Northern Trust’s Senti Biosciences Holdings SNTI Stock Holding History

Northern Trust’s Portfolio SNTI Stock Details SNTI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$35.4K	Buy	32,154 +15,376	+92%	+$15K	﹤0.01%	4317
2026 Q1	$13.6K	Hold	16,778	–	–	﹤0.01%	4361
2025 Q4	$17.4K	Buy	16,778 +468	+3%	+$827	﹤0.01%	4404
2025 Q3	$23K	Buy	+16,310	New	+$27.3K	﹤0.01%	4362
2024 Q3	–	Sell	-3,685	Closed	-$10.2K	–	4447
2024 Q2	$10.2K	Hold	3,685	–	–	﹤0.01%	4381
2024 Q1	$13.9K	Hold	3,685	–	–	﹤0.01%	4369
2023 Q4	$24.3K	Hold	3,685	–	–	﹤0.01%	4339
2023 Q3	$15.2K	Hold	3,685	–	–	﹤0.01%	4367
2023 Q2	$23.1K	Hold	3,685	–	–	﹤0.01%	4378
2023 Q1	$43.5K	Buy	3,685 +2,255	+158%	+$35.1K	﹤0.01%	4289
2022 Q4	$20.2K	Hold	1,430	–	–	﹤0.01%	4485
2022 Q3	$31K	Buy	+1,430	New	+$28.2K	﹤0.01%	4452

Other funds holding SNTI

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

MVM

Menlo Ventures Management Menlo Park, California $357M AUM

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Northern Trust's SNTI Position: Q2 2026 in Review

Northern Trust increased its Senti Biosciences Holdings (SNTI) stake by 92% in Q2 2026, buying an estimated $15K and bringing the position to 32,154 shares worth $35.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4317.

Northern Trust first reported a position in SNTI in Q3 2022 and has held it in 12 quarters since. The position peaked at $43.5K in Q1 2023. 17 funds tracked by Wall St. Rank hold SNTI as of Q2 2026.

Northern Trust held 32,154 shares of Senti Biosciences Holdings worth $35.4K as of Q2 2026.
Northern Trust bought 15,376 Senti Biosciences Holdings shares in Q2 2026, an estimated $15K.
Senti Biosciences Holdings made up ﹤0.01% of Northern Trust's portfolio in Q2 2026, its #4317 holding.
Northern Trust first reported a position in Senti Biosciences Holdings in Q3 2022 and has held it in 12 quarters since.
Northern Trust's Senti Biosciences Holdings position peaked at $43.5K in Q1 2023.
17 funds tracked by Wall St. Rank held Senti Biosciences Holdings as of Q2 2026.

Based on Northern Trust's 13F filing for Q2 2026, filed 13 Aug 2026.